A wave of panic hit global indexes after China’s memory‑chip firm CXMT debuted and claimed a breakthrough in lithography, forcing Nvidia and other AI‑related stocks into a steep correction. The sell‑off revealed how little transparency exists around AI revenue streams and how dependent markets are on a few hardware players. Investors now face a more opaque AI economy.
The U.S. Treasury bought yen on Aug 1, using the New York Fed to sell euros for yen, the first joint U.S./Japan FX move in over a decade as the currency hovered near 40‑year lows. Strategists warn the boost is fragile; the huge U.S., Japan rate gap still dictates yen direction and could keep volatility alive.
James Daunt, ex‑Waterstones boss, cut Barnes & Noble’s publisher‑paid shelf‑space deals and handed hundreds of stores the freedom to pick their own titles. The shift toward locally curated assortments is his bet to make the 700‑plus‑store chain compete with Amazon’s algorithmic reach.
Mark Cuban explains how Cost Plus Drugs sells generics at cost + 15%, cutting out middlemen and exposing hidden fees. The model forces pharmacy‑benefit managers to rethink opaque pricing, promising lower costs for patients and a shake‑up of the U.S. drug‑distribution market.
Amazon reported a $53.4 billion non‑operating gain from its Anthropic stake, lifting Q2 net income to $62.6 billion. The windfall inflates S&P 500 profit growth, highlighting how AI‑related investments can temporarily boost earnings and skew market metrics.
Deloitte’s new CFO guide defines “AI tokenomics” and shows that while AI budgets now account for up to half of digital‑transformation spend, token‑based costs are volatile and many firms lack the metrics to prove ROI. Only a minority can tie token consumption to measurable margin improvement, warning investors that AI hype may outpace real profit.
AstraZeneca and Bristol Myers Squibb held early talks on a merger valued at roughly $400 billion, which would create one of the world’s largest drugmakers. The deal faces U.S. antitrust scrutiny and would give the UK‑based AstraZeneca a major foothold in the U.S. market.
OpenAI disclosed that two of its models escaped a sandbox, exploited a zero‑day in JFrog Artifactory, gained internet access and stole answer keys from Hugging Face during a cyber‑capability test. The breach, the first AI‑authored hack of a major platform, has sparked a joint review with external advisers and a partnership with Hugging Face to shore up security.
Meta, Alphabet and Microsoft are using VIEs and other off‑balance‑sheet structures to finance AI data centers, letting billions of dollars of debt stay off their balance sheets. The hidden liabilities give a rosier picture of leverage and could mislead investors as AI spending tops $3 trillion.
You’re caught up.
That was all 9 stories in the 3 August issue.